Page last updated: 2024-08-26

nicotine and 2,3-dinor-6-ketoprostaglandin f1alpha

nicotine has been researched along with 2,3-dinor-6-ketoprostaglandin f1alpha in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benowitz, NL; Fitzgerald, GA; Wilson, M; Zhang, Q	1

Trials

1 trial(s) available for nicotine and 2,3-dinor-6-ketoprostaglandin f1alpha

Article	Year
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. Journal of the American College of Cardiology, 1993, Volume: 22, Issue:4 Topics: 6-Ketoprostaglandin F1 alpha; Administration, Cutaneous; Adult; Aged; beta-Thromboglobulin; Blood Coagulation; Cell Adhesion Molecules; Coronary Disease; Eicosanoids; Factor VII; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Nicotine; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Factor 4; Platelet Membrane Glycoproteins; Risk Factors; Smoking; Smoking Cessation; Thromboxane A2; Thromboxane B2	1993

Article

Year

Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.

Journal of the American College of Cardiology, 1993, Volume: 22, Issue:4

Topics: 6-Ketoprostaglandin F1 alpha; Administration, Cutaneous; Adult; Aged; beta-Thromboglobulin; Blood Coagulation; Cell Adhesion Molecules; Coronary Disease; Eicosanoids; Factor VII; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Nicotine; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Factor 4; Platelet Membrane Glycoproteins; Risk Factors; Smoking; Smoking Cessation; Thromboxane A2; Thromboxane B2

1993